This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Apr;128(4):506-8.

doi: 10.1001/archophthalmol.2010.24.

Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration

Robin Casten, Barry W Rovner, Benjamin E Leiby, William Tasman

PMID: 20385955
DOI: 10.1001/archophthalmol.2010.24

Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration

Robin Casten et al. Arch Ophthalmol. 2010 Apr.

. 2010 Apr;128(4):506-8.

doi: 10.1001/archophthalmol.2010.24.

Authors

Robin Casten, Barry W Rovner, Benjamin E Leiby, William Tasman

PMID: 20385955
DOI: 10.1001/archophthalmol.2010.24

No abstract available

PubMed Disclaimer

Similar articles

When should anti-vascular endothelial growth factor treatment be stopped in age-related macular degeneration?
Gaudric A, Cohen SY. Gaudric A, et al. Am J Ophthalmol. 2010 Jan;149(1):4-6. doi: 10.1016/j.ajo.2009.08.039. Am J Ophthalmol. 2010. PMID: 20103036 No abstract available.
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
Pedersen KB, Sjølie AK, Møller F. Pedersen KB, et al. Acta Ophthalmol. 2009 Nov;87(7):714-9. doi: 10.1111/j.1755-3768.2008.01346.x. Epub 2008 Dec 16. Acta Ophthalmol. 2009. PMID: 19094171
Microperimetric changes after intravitreal bevacizumab for exudative age-related macular degeneration.
Rensch F, Jonas JB. Rensch F, et al. Acta Ophthalmol. 2008 Sep;86(6):696-7. doi: 10.1111/j.1600-0420.2007.01131.x. Acta Ophthalmol. 2008. PMID: 18752522 No abstract available.
[Safety aspect of age macular degeneration treatment].
Zyrianov SK, Belousov IuB. Zyrianov SK, et al. Vestn Oftalmol. 2012 Jul-Aug;128(4):75-7. Vestn Oftalmol. 2012. PMID: 22994114 Review. Russian. No abstract available.
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis.
Schmid MK, Bachmann LM, Fäs L, Kessels AG, Job OM, Thiel MA. Schmid MK, et al. Br J Ophthalmol. 2015 Feb;99(2):141-6. doi: 10.1136/bjophthalmol-2014-305149. Epub 2014 Jun 11. Br J Ophthalmol. 2015. PMID: 25271911 Review.

See all similar articles

Cited by

Effect of Needle Gauge Size on Pain During Intravitreal Anti-VEGF Injection: A Systematic Review and Network Meta-Analysis.
Butler ETS, Bjerager J, Eriksen NS, Hajari JN, Schneider M, Faber C, Subhi Y. Butler ETS, et al. Ophthalmol Ther. 2024 Mar;13(3):801-817. doi: 10.1007/s40123-023-00879-7. Epub 2024 Jan 24. Ophthalmol Ther. 2024. PMID: 38265622 Free PMC article.
Economic evaluation of an e-mental health intervention for patients with retinal exudative diseases who receive intraocular anti-VEGF injections (E-PsEYE): protocol for a randomised controlled trial.
van der Aa HPA, van Rens GHMB, Verbraak FD, Bosscha M, Koopmanschap MA, Comijs HC, Cuijpers P, van Nispen RMA. van der Aa HPA, et al. BMJ Open. 2017 Nov 15;7(11):e018149. doi: 10.1136/bmjopen-2017-018149. BMJ Open. 2017. PMID: 29146648 Free PMC article. Clinical Trial.
Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis.
Parravano M, Petri D, Maurutto E, Lucenteforte E, Menchini F, Lanzetta P, Varano M, van Nispen RMA, Virgili G. Parravano M, et al. JAMA Ophthalmol. 2021 Jul 1;139(7):753-761. doi: 10.1001/jamaophthalmol.2021.1557. JAMA Ophthalmol. 2021. PMID: 34042966 Free PMC article. Review.
Update on depression and age-related macular degeneration.
Casten RJ, Rovner BW. Casten RJ, et al. Curr Opin Ophthalmol. 2013 May;24(3):239-43. doi: 10.1097/ICU.0b013e32835f8e55. Curr Opin Ophthalmol. 2013. PMID: 23429599 Free PMC article. Review.
Anxiety and depression in patients who receive anti-VEGF treatment and the usability and feasibility of e-mental health support: the E-PsEYE pilot study.
van der Aa HP, van Rens GH, Verbraak FD, Bosscha M, Comijs HC, van Nispen RM. van der Aa HP, et al. Ophthalmic Physiol Opt. 2021 Jul;41(4):808-819. doi: 10.1111/opo.12837. Epub 2021 May 29. Ophthalmic Physiol Opt. 2021. PMID: 34050550 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information